Cite
Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma
MLA
Axel Haferkamp, et al. “Prognostic and Predictive Value of Tumor-Infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.” Translational Oncology, vol. 13, no. 2, Dec. 2019, pp. 336–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9a889b26e7a3b4cb843b37b873e8a58c&authtype=sso&custid=ns315887.
APA
Axel Haferkamp, Markus Hohenfellner, Mario Schindeldecker, Esther Herpel, Katrin E. Tagscherer, Gencay Hatiboglu, Sebastian Foersch, Stephan Macher-Goeppinger, Christian Thomas, Wilfried Roth, Philipp Stenzel, & Juergen Alt. (2019). Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma. Translational Oncology, 13(2), 336–345.
Chicago
Axel Haferkamp, Markus Hohenfellner, Mario Schindeldecker, Esther Herpel, Katrin E. Tagscherer, Gencay Hatiboglu, Sebastian Foersch, et al. 2019. “Prognostic and Predictive Value of Tumor-Infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.” Translational Oncology 13 (2): 336–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9a889b26e7a3b4cb843b37b873e8a58c&authtype=sso&custid=ns315887.